P-284Gevokizumab, an interleukin-1β (IL-1β) monoclonal antibody (mAb), in metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer (mGEC) and metastatic renal cell carcinoma (mRCC): "first-in-cancer" phase Ib study. (2nd July 2019) - Van Cutsem, E; Shitara, K; Deng, W; Vaury, A; Tseng, L; Wang, X; Millholland, J; Shilkrut, M; Mookerjee, B; Jonasch, E